12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

Itamar Medical Ltd., Roche deal

Itamar received a $250,000 milestone payment from Roche under a 2010 deal to develop an EndoPAT device for Roche to assess endothelial dysfunction of cardiovascular...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >